4.7 Article

Continuous glucose monitoring-based time-in-range using insulin glargine 300 units/ml versus insulin degludec 100 units/ml in type 1 diabetes: The head-to-head randomized controlled InRange trial

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Endocrinology & Metabolism

Comparison of Second-Generation Basal Insulin Analogs: A Review of the Evidence from Continuous Glucose Monitoring

Tadej Battelino et al.

Summary: The review of current CGM evidence for second-generation basal insulins in both people with type 1 and type 2 diabetes highlights the complexity of evaluating basal insulins with various CGM-related metrics. The identified studies had small sample sizes, short durations, and lacked statistically significant between-treatment differences. There is a need for further studies on second-generation basal insulin analogs considering standard metrics proposed by the TIR consensus group, with attention to sample size and study duration.

DIABETES TECHNOLOGY & THERAPEUTICS (2021)

Article Endocrinology & Metabolism

6. Glycemic Targets: Standards of Medical Care in Diabetes-2021

Summary: The ADA Standards of Medical Care in Diabetes offers recommendations and guidelines for diabetes care, with updates made by a multidisciplinary expert committee annually. Readers are invited to provide feedback on the standards through the professional website.

DIABETES CARE (2021)

Article Endocrinology & Metabolism

The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Richard I. G. Holt et al.

Summary: This article discusses a consensus statement on the management of type 1 diabetes in adults, covering various aspects such as diagnosis, treatment goals, self-management education and support, with the aim of helping healthcare professionals better manage patients with this condition.

DIABETES CARE (2021)

Article Endocrinology & Metabolism

Effectiveness and Safety of Insulin Glargine 300 U/ml in Comparison with Insulin Degludec 100 U/ml Evaluated with Continuous Glucose Monitoring in Adults with Type 1 Diabetes and Suboptimal Glycemic Control in Routine Clinical Practice: The OneCARE Study

Ignacio Conget et al.

Summary: This study evaluated the efficacy of second-generation basal insulins in sub-optimally controlled T1D patients, showing that insulin glargine and insulin degludec had similar TIR during the whole day, but glargine had significantly higher TIR and lower time above range at night compared to degludec. Patient satisfaction with both insulins was high and similar.

DIABETES THERAPY (2021)

Article Endocrinology & Metabolism

The Beneficial Effects of Earlier Versus Later Implementation of Intensive Therapy in Type 1 Diabetes

John M. Lachin et al.

Summary: In patients with type 1 diabetes, earlier implementation of intensive therapy compared to later implementation is associated with a greater reduction in the risks of kidney and cardiovascular complications.

DIABETES CARE (2021)

Article Endocrinology & Metabolism

Pharmacokinetic and Pharmacodynamic Head-to-Head Comparison of Clinical, Equivalent Doses of Insulin Glargine 300 units . mL(-1) and Insulin Degludec 100 units . mL(-1) in Type 1 Diabetes

Paola Lucidi et al.

Summary: Individualized, clinically titrated doses of Gla-300 and Deg-100 in patients with type 1 diabetes result in similar glycemic control and glucose pharmacodynamics equivalence under steady state conditions.

DIABETES CARE (2021)

Review Public, Environmental & Occupational Health

Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis

Majid Mobasseri et al.

HEALTH PROMOTION PERSPECTIVES (2020)

Article Endocrinology & Metabolism

Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials

Roy W. Beck et al.

DIABETES CARE (2019)

Article Endocrinology & Metabolism

State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018

Nicole C. Foster et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2019)

Article Endocrinology & Metabolism

Optimal Sampling Duration for Continuous Glucose Monitoring to Determine Long-Term Glycemic Control

Tonya D. Riddlesworth et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2018)

Article Endocrinology & Metabolism

Continuous glucose monitoring detected hypoglycaemia in the Treating to Target in Type 2 Diabetes Trial (4-T)

J. C. Levy et al.

DIABETES RESEARCH AND CLINICAL PRACTICE (2017)

Review Biochemistry & Molecular Biology

Comparison of the pharmacokinetic and pharmacodynamic profiles of insulin degludec and insulin glargine

Tim Heise et al.

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2015)

Article Endocrinology & Metabolism

Does Glycemic Variability Impact Mood and Quality of Life?

Sue Penckofer et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2012)

Article Endocrinology & Metabolism

Fear of hypoglycaemia in adults with Type 1 diabetes

T. Anderbro et al.

DIABETIC MEDICINE (2010)